Acute Coronary SyndromeBoomerangACSNCT03727984
Re-hospitalized Patients With Acute Coronary Syndrome
An observational study of Acute Coronary Syndrome, run by Cardiovascular Academy Society, Turkey at 1 site in Turkey (Türkiye).
Trial summary
The predictors of re-hospitalization of patients with history of acute coronary syndrome Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Acute Coronary Syndrome
- How many people
- 577 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Nov 2018to 15 Nov 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Adult, Older adult
Study population: The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months. To the best of our knowledge, this is the first study to evaluate the characteristics of re-hospitalized patients for ACS. The case report forms which attached in excel must be filled by investigators case by case based on recorded data.
Who may be able to join
- Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months
Who cannot join
- Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Demographic, Clinical Characteristics and Medications of Re-hospitalized Patients for Acute Coronary Syndrome
The predictors of re-hospitalization of patients with history of acute coronary syndrome
Read the detailed description
The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.
- Conditions
- Acute Coronary Syndrome
- Keywords
- Myocardial infarction, Hospitalization, Coronary artery disease, Retrospective, Cohort study
- Medical subject headings
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome
The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code
Measured: Up to 1 year
Cardiovascular Hospitalization
Predictive factors for patients re-admitted with acute coronary
Measured: Up to 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Nov 2018
- Study start15 Nov 2018
- Primary completion15 Sep 2019
- Study completion15 Nov 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 577 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cardiovascular Academy Society, Turkey
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehdi Zoghi, Cardiovascular Academy Society, Turkey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03727984
- Sponsor's protocol ID
- 2018-2
- Acronym
- BoomerangACS
- Status last verified
- Jan 2020
- First submitted
- 30 Oct 2018
- Last updated
- 23 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Demographic, Clinical Characteristics and Medications of Re-hospitalized Patients for Acute Coronary Syndrome
- ClinicalTrials.gov ID
- NCT03727984
- Acronym / sponsor ID
- BoomerangACS / 2018-2
- Conditions
- Acute Coronary Syndrome
- Keywords
- Myocardial infarction, Hospitalization, Coronary artery disease, Retrospective, Cohort study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 577 participants (actual)
- Lead sponsor
- Cardiovascular Academy Society, TurkeyUniversity, hospital or other
- Study start
- 15 Nov 2018 (actual)
- Primary completion
- 15 Sep 2019 (actual)
- Study completion
- 15 Nov 2019 (actual)
- First posted
- 1 Nov 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The predictors of re-hospitalization of patients with history of acute coronary syndrome
Detailed description
The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months. To the best of our knowledge, this is the first study to evaluate the characteristics of re-hospitalized patients for ACS. The case report forms which attached in excel must be filled by investigators case by case based on recorded data.
Key inclusion criteria (1 listed)
- Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months
Key exclusion criteria (1 listed)
- Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome
Time frame: Up to 1 year
The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code
Cardiovascular Hospitalization
Time frame: Up to 1 year
Predictive factors for patients re-admitted with acute coronary
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2020.
Related trials for Acute Coronary Syndrome
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Coronary Syndrome, run by Cardiovascular Academy Society, Turkey at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome (time frame: Up to 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020.